在帕金森病中分子伴侣集群蛋白的新兴作用
Giulia Carini1, Salihu Mohammed2, Alice Filippini1,3
1Unit of Biology and Genetics, Department of Molecular and Translational Medicine, University of Brescia, Via Europa 11, 25123 Brescia, Italy.
International journal of molecular sciences
|July 12, 2025
概括
集群蛋白 (CLU) 涉及帕金森病 (PD) 病原发生. 本综述探讨了CLU在α-synuclein聚合中的作用及其作为PD生物标志物和治疗点的潜力.
科学领域:
- 神经科学是一个神经科学.
- 分子生物学分子生物学
- 生物化学 生化学
背景情况:
- 集群蛋白 (CLU) 是一种脑表达的分子伴侣.
- 慢性肺炎与阿尔茨海默氏症有关,并且越来越多地与帕金森病 (PD) 有关.
- 阿尔法-合成核素 (α-Syn) 聚合是PD病理学的核心.
研究的目的:
- 审查CLU在PD病变发生过程中的参与.
- 专注于CLU在α-Syn聚合物形成和扩散中的作用.
- 讨论CLU作为PD生物标志物和治疗点的潜力.
主要方法:
- 关于CLU和PD研究的文献综述.
- 分析了CLU在神经元和质细胞中的功能.
- 在神经退行症中检查神经元-质交叉交谈.
主要成果:
- 在PD中,CLU影响α-Syn聚合和扩散.
- CLU在神经元和质细胞中发挥作用.
- 神经元-质细胞的沟通至关重要,在PD中受损.
结论:
- CLU是PD病变发生的一个重要因素.
- 在α-Syn病理学中CLU的作用突出了其治疗潜力.
- 在生物流体中,CLU可以作为PD的生物标志物.
相关概念视频
Molecular Chaperones and Protein Folding
18.5K
The native conformation of a protein is formed by interactions between the side chains of its constituent amino acids. When the amino acids cannot form these interactions, the protein cannot fold by itself and needs chaperones. Notably, chaperones do not relay any additional information required for the folding of polypeptides; the native conformation of a protein is determined solely by its amino acid sequence. Chaperones catalyze protein folding without being a part of the folded protein.
The...
The...
18.5K
Parkinson's Disease: Overview
715
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
715
Neural Regulation
40.2K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
40.2K
Parkinson's Disease: Treatment
385
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
385
Amyloid Fibrils
9.9K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
9.9K
Lysosomal Hydrolases
3.9K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
3.9K


